Acceleron Pharma Inc (NASDAQ:XLRN)

35.07
Delayed Data
As of May 21
 -0.67 / -1.87%
Today’s Change
24.37
Today|||52-Week Range
46.93
-17.37%
Year-to-Date
No recent news for Acceleron Pharma Inc.

Today’s Trading

Previous close35.74
Today’s open35.89
Day’s range34.52 - 36.21
Volume208,731
Average volume (3 months)310,803
Market cap$1.6B
Data as of 4:00pm ET, 05/21/2018

Growth & Valuation

Earnings growth (last year)-76.32%
Earnings growth (this year)+10.53%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales127.25
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...-0.05-0.21%
RDUSRadius Health Inc-2.38-7.58%
SGMOSangamo Therapeutics...-0.45-2.82%
HALOHalozyme Therapeutic...-0.34-1.83%
Data as of 4:00pm ET, 05/21/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$13.5M
Annual profit (last year)-$108.5M
Net profit margin-804.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Habib J. Dable
SVP-Program Management &
Operations
Christopher Rovaldi
Corporate headquarters
Cambridge, Massachusetts

Forecasts